Novel Immunotherapy approaches to engaging the Innate Immune System
In this podcast episode, Dr. Michael Alonso, VP of Immunology and Pharmacology at Bolt Biotherapeutics, discusses how the company is developing cancer therapies that engage the innate immune system to generate robust anti-tumor responses.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.